AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pulmonx Corp Director's Dealing 2022

Sep 6, 2022

34428_dirs_2022-09-06_9f32f832-ed53-4aae-a03a-14bf96e44bd5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2022-09-01

Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-01	Common Stock	S	372	$17.87	Disposed	182747	Direct
2022-09-01	Common Stock	S	655	$17.90	Disposed	182092	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2: Includes 1 share acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 15, 2022.

F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022.